Cushman & Wakefield Ltd.
$5.17B- Market cap
- $3.21B
- Debt
- +$2.75B
- Cash
- −$784.20M
Capital structure 54% equity / 46% debt · EV / Revenue 0.50x · EV / EBITDA 9.77x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: CWK stock price at discount vs RVMD $13.66 current versus $170.39K implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at RVMD's multiple
Implied fair value · at CWK's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CWK FY 2025 (ended Dec 31, 2025) · RVMD FY 2023 (ended Dec 31, 2023). Fiscal years are not aligned.
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 54% equity / 46% debt · EV / Revenue 0.50x · EV / EBITDA 9.77x
Capital structure 100% equity / 0% debt · EV / Revenue 3744.03x
RVMD carries the larger enterprise value at $43.36B against $5.17B; CWK trades on the lower EV / Revenue multiple (0.50x vs 3744.03x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Cushman & Wakefield Ltd. · implied price per share
Bear
$1.12
Base
$2.79
Bull
$4.98
Revolution Medicines, Inc. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.41x
0.11x
Net debt / EBITDA
Leverage against operating earnings
3.71x
3.85x
Cash and equivalents
Liquid reserves on the balance sheet
$784.20M
$1.85B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
JONES LANG LASALLE INC
CWK vs JLL
CBRE GROUP, INC.
CWK vs CBRE
Marcus & Millichap, Inc.
CWK vs MMI
COSTAR GROUP, INC.
CWK vs CSGP
RMR GROUP INC.
CWK vs RMR
AMGEN INC
CWK vs AMGN
BRISTOL MYERS SQUIBB CO
CWK vs BMY
GILEAD SCIENCES, INC.
CWK vs GILD
INCYTE CORP
CWK vs INCY
VERTEX PHARMACEUTICALS INC / MA
CWK vs VRTX
Moderna, Inc.
CWK vs MRNA
$2.75B
$193.93M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.